Norwegian-British cancer medicine to be tested on British COVID-19 patients
ScienceNordic,
BerGenBio believes it is 80 per cent likely that their bemcentinib pill will help people who are sick with the coronavirus.
TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis
Overview of attention for article published in PLoS Neglected Tropical Diseases, June 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (81st percentile)
-
Good Attention Score compared to outputs of the same age and source (71st percentile)
Readers on
- mendeley
- 75 Mendeley